Edus Warren is an Oncology physician affiliated with University of Washington. OpenAlex indexes 274 publications with 10,299 citations (h-index 50); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Washington Medical Ctr
1959 NE Pacific St
Seattle, WA 981950001
Telephone
206-288-1000Registry record last updated 28 Jan 2013.
Clinical trials
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ROCHE MOLECULAR SYSTEMS, INC.Program year20249 payments
- Epizyme, Inc.,Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
65.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor65.1%Acyclovir100%Part D<11 patientsAnti-infectives
34.9%Short-acting sulfonamides34.9%Sulfamethoxazole-Trimethoprim100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1999–2025 per NIH RePORTER. The latest:
- Comprehensive Characterization of the T-cell Response to KSHV to Enable Specific Immune Therapy
Fred Hutchinson Cancer Center
FY2025$4,234,248U01CA295053 - HIV persistence and treatment response in Kaposi sarcoma
Fred Hutchinson Cancer Center
FY2025$432,098R21CA302296 - Training in Cancer Genomics and Genomic Data Science
Fred Hutchinson Cancer Center
FY2025$230,816D43CA260656
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Precision Medicine in Low- and Middle-Income Countries
Annual Review of Pathology Mechanisms of Disease
2022 - Outcomes of patients with large B‐cell lymphomas and progressive disease following CD19‐specific CAR T‐cell therapy
American Journal of Hematology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Neal Futran, MD, DMD
University of Washington
Elizabeth Swisher
University of Washington
David Tirschwell
University of Washington
Elaine Peskind, MD
University of Washington
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”